Sanofi: Filing of the 2018 U.S. Form 20-F and French « Document de Référence » containing the Annual Financial Report
08 Marzo 2019 - 1:50PM
| |
Press
Release Source: Sanofi (EURONEXT: SAN) (NASDAQ: SNY)
|
Filing of the 2018 U.S. Form 20-F and French
« Document de Référence » containing the Annual Financial
Report
PARIS, France - March 8, 2019 - Sanofi
announces today the filing of its Form 20-F with the U.S.
Securities and Exchange Commission (SEC) and its "Document de
Référence" containing its Annual Financial Report with the French
market regulator Autorité des marchés financiers (AMF).
These documents are available on the company's
website:
https://www.sanofi.com/en/investors/reports-and-publications/financial-and-csr-reports.
In addition, the Form 20-F is available on the website of the SEC
(www.sec.gov) and the "Document de Référence" is available on the
website of the AMF (www.amf-france.org). A hard copy of these
documents, each of which contains our complete audited financial
statements, may be received free of charge, upon request.
|
About Sanofi Sanofi is dedicated to supporting
people through their health challenges. We are a global
biopharmaceutical company focused on human health. We prevent
illness with vaccines, provide innovative treatments to fight pain
and ease suffering. We stand by the few who suffer from rare
diseases and the millions with long-term chronic conditions.
With more than 100,000 people in 100 countries, Sanofi is
transforming scientific innovation into healthcare solutions around
the globe. Sanofi, Empowering Life |
|
Media Relations Contact Quentin Vivant Tel.: +33 (0)1 53 77
46 46 mr@sanofi.com |
Investor Relations
Contact George Grofik Tel.: +33 (0)1 53 77 45 45
ir@sanofi.com |
| |
Sanofi (EU:SAN)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Sanofi (EU:SAN)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
